Endothelin Receptor Antagonists

Preferred Label : Endothelin Receptor Antagonists;

MeSH definition : Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS.;

MeSH synonym : Antagonists, Endothelin Receptor; Endothelin Antagonists; Antagonists, Endothelin; Endothelin Receptor Antagonist; Antagonist, Endothelin Receptor; Receptor Antagonist, Endothelin; Endothelin Antagonist; Antagonist, Endothelin;

Is substance : O;

Details

Origin ID

D065128;

UMLS CUI

C1134681;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Endothelin Receptor Antagonist [NCIt concept]
- Substance with endothelin receptor antagonist mechanism of action (substance) [SNOMED CT concept]
False automatic mappings
- Are [NCIt concept]
- are [UCUM unit]
MeSH Descriptor(s) used for indexing
- receptors, endothelin [MeSH Descriptor]
Record concept(s)
- Endothelin Receptor Antagonists [MeSH concept]
See also inter- (CISMeF)
- Endothelin receptor antagonist (disposition) [SNOMED CT concept]
- Product containing endothelin receptor antagonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-cyano-3,3-diphenylpropionic acid [MeSH Supplementary Concept]
- 2-(2-cyano-5-(pyrid-4-yl)methoxy)phenoxy-2-(2-methyl)phenylacetic acid [MeSH Supplementary Concept]
- 2-(3-fluoro-4-methylphenyl)-4-(2,3-dihydrobenzofuran-5-yl)-1-(N,N-dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid [MeSH Supplementary Concept]
- 3-(5-(4-benzo(1,3)dioxol-5-yl-2-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydrofuran-3-ylmethyl)-2,3-dimethoxyphenoxy)propane-1-sulfonic acid [MeSH Supplementary Concept]
- 4-(2-cyano-5-(3-pyridylmethoxy)phenoxy)-4-(2-methylphenyl)butanoic acid [MeSH Supplementary Concept]
- 7-deacetyl-5-dechloro-1,O(8),8,8a-tetrahydro-7-epi-sclerotiorin [MeSH Supplementary Concept]
- 97-618 compound [MeSH Supplementary Concept]
- A 216546 [MeSH Supplementary Concept]
- ATZ1993 [MeSH Supplementary Concept]
- BMS 184696 [MeSH Supplementary Concept]
- BMS 184697 [MeSH Supplementary Concept]
- BMS 187308 [MeSH Supplementary Concept]
- BMS 193884 [MeSH Supplementary Concept]
- BQ 238 [MeSH Supplementary Concept]
- BQ 928 [MeSH Supplementary Concept]
- BSF 302146 [MeSH Supplementary Concept]
- Bosentan [MeSH Descriptor]
- CGS 27830 [MeSH Supplementary Concept]
- IRL 3461 [MeSH Supplementary Concept]
- J 104132 [MeSH Supplementary Concept]
- J-105859 [MeSH Supplementary Concept]
- L 744453 [MeSH Supplementary Concept]
- LU 224332 [MeSH Supplementary Concept]
- N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,3,3-trimethylbutanamide [MeSH Supplementary Concept]
- N-(6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-5-(4-methylphenyl)-4-pyrimidinyl)-4-tert-butylbenzenesulfonamide [MeSH Supplementary Concept]
- N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide [MeSH Supplementary Concept]
- PD 156252 [MeSH Supplementary Concept]
- PD 161721 [MeSH Supplementary Concept]
- PD 164333 [MeSH Supplementary Concept]
- PD 164800 [MeSH Supplementary Concept]
- RES 1214-1 [MeSH Supplementary Concept]
- RES 1214-2 [MeSH Supplementary Concept]
- RES 701-1 [MeSH Supplementary Concept]
- RES 701-2 [MeSH Supplementary Concept]
- RES 701-3 [MeSH Supplementary Concept]
- RES 701-4 [MeSH Supplementary Concept]
- RPR 111723 [MeSH Supplementary Concept]
- S 0139 [MeSH Supplementary Concept]
- SB 247083 [MeSH Supplementary Concept]
- T 0201 [MeSH Supplementary Concept]
- TBC 2576 [MeSH Supplementary Concept]
- TTA 386 [MeSH Supplementary Concept]
- ZD 1611 [MeSH Supplementary Concept]
- ZD 2574 [MeSH Supplementary Concept]
- cyclo(Trp-Asp-Pro-Val-Leu) [MeSH Supplementary Concept]
- cyclo(tryptophyl-aspartyl-prolyl-isoleucyl-leucyl) [MeSH Supplementary Concept]
- cyclo(tryptophyl-aspartyl-prolyl-valyl-N-methylleucyl) [MeSH Supplementary Concept]
- darusentan [MeSH Supplementary Concept]
- endothelin-1, Ala(10)- [MeSH Supplementary Concept]
- endothelin-1, Ala(9)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-Cha(19)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-Leu(19)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-gamma-methyl-Leu(19)- [MeSH Supplementary Concept]
- enrasentan [MeSH Supplementary Concept]
- isochromophilone III [MeSH Supplementary Concept]
- ro 46-2005 [MeSH Supplementary Concept]
- ro 48-5695 [MeSH Supplementary Concept]
- sitaxsentan [MeSH Supplementary Concept]
- stachybocin A [MeSH Supplementary Concept]
- stachybocin B [MeSH Supplementary Concept]
- stachybocin C [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Endothelin Receptor Antagonist [NCIt concept]
- Product containing endothelin receptor antagonist (product) [SNOMED CT concept]
- Substance with endothelin receptor antagonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients